U.S. markets closed
  • S&P Futures

    3,831.00
    -8.00 (-0.21%)
     
  • Dow Futures

    31,488.00
    +23.00 (+0.07%)
     
  • Nasdaq Futures

    12,556.25
    -107.50 (-0.85%)
     
  • Russell 2000 Futures

    2,192.60
    +2.90 (+0.13%)
     
  • Crude Oil

    67.47
    +1.38 (+2.09%)
     
  • Gold

    1,702.00
    +3.50 (+0.21%)
     
  • Silver

    25.66
    +0.37 (+1.48%)
     
  • EUR/USD

    1.1906
    -0.0018 (-0.15%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • Vix

    24.66
    -3.91 (-13.69%)
     
  • GBP/USD

    1.3823
    -0.0005 (-0.03%)
     
  • USD/JPY

    108.3970
    +0.0150 (+0.01%)
     
  • BTC-USD

    50,483.17
    +755.19 (+1.52%)
     
  • CMC Crypto 200

    1,021.09
    +77.91 (+8.26%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    28,721.66
    -142.66 (-0.49%)
     

WALMART INVESTOR ALERT: Shareholder Class Action Lawsuit Filed

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

BOSTON, MA / ACCESSWIRE / January 25, 2021 / The Thornton Law Firm announces that a class action lawsuit has been filed on behalf of investors of Walmart Inc. (NYSE:WMT). The case is currently in the lead plaintiff stage. Investors who purchased Walmart stock or other securities between March 30, 2016 and December 22, 2020 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Walmart to submit their information. Investors may also email investors@tenlaw.com or call 617-531-3917.

FOR MORE INFORMATION: www.tenlaw.com/cases/Walmart

The case alleges that Walmart and its senior executives made misleading statements to investors and failed to disclose that: (1) Walmart knowingly filled prescriptions that were issued by so-called "pill-mill" prescribers; (2) Walmart filled thousands of prescriptions that showed obvious red flags, including highly-dangerous cocktails of drugs; (3) Walmart's managers made it difficult for its pharmacists to comply with their legal obligations by pressuring them to fulfill as many orders as possible; (4) hence, Walmart's pharmacy revenues were inflated because Walmart filled thousands of invalid prescriptions in violation of the Controlled Substance Act dispensing requirements; and (5) the aforementioned conduct would subject Walmart to regulatory scrutiny.

Interested Walmart investors have until March 22, 2021 to retain counsel and apply to be a lead plaintiff if they are interested to do so. Investors do not need to be a lead plaintiff in order to be a class member. A lead plaintiff acts on behalf of all other investor class members in managing the class action. If investors choose to take no action, they can remain an absent class member. The class has not yet been certified. Until certification occurs, investors are not represented by an attorney.

FOR MORE INFORMATION: www.tenlaw.com/cases/Walmart

Thornton Law Firm's securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of investors. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

CONTACT:

Thornton Law Firm LLP
1 Lincoln Street
State Street Financial Center
Boston, MA 02111

www.tenlaw.com/cases/Walmart

SOURCE: Thornton Law Firm LLP



View source version on accesswire.com:
https://www.accesswire.com/625858/WALMART-INVESTOR-ALERT-Shareholder-Class-Action-Lawsuit-Filed